Correlation Between GH Research and PsyBio Therapeutics

Can any of the company-specific risk be diversified away by investing in both GH Research and PsyBio Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GH Research and PsyBio Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between GH Research PLC and PsyBio Therapeutics Corp, you can compare the effects of market volatilities on GH Research and PsyBio Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GH Research with a short position of PsyBio Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of GH Research and PsyBio Therapeutics.

Diversification Opportunities for GH Research and PsyBio Therapeutics

-0.02

Correlation Coefficient

GH Research  PsyBio Therapeutics

Good diversification

The 3 months correlation between GHRS and PsyBio is -0.02. Overlapping area represents the amount of risk that can be diversified away by holding GH Research PLC and PsyBio Therapeutics Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PsyBio Therapeutics Corp and GH Research is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GH Research PLC are associated (or correlated) with PsyBio Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PsyBio Therapeutics Corp has no effect on the direction of GH Research i.e., GH Research and PsyBio Therapeutics go up and down completely randomly.

Pair Corralation between GH Research and PsyBio Therapeutics

Given the investment horizon of 90 days GH Research is expected to generate 69.84 times less return on investment than PsyBio Therapeutics. But when comparing it to its historical volatility, GH Research PLC is 28.86 times less risky than PsyBio Therapeutics. It trades about 0.04 of its potential returns per unit of risk. PsyBio Therapeutics Corp is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest  0.01  in PsyBio Therapeutics Corp on September 12, 2024 and sell it today you would earn a total of  0.00  from holding PsyBio Therapeutics Corp or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

GH Research PLC  vs.  PsyBio Therapeutics Corp

GH Research PLC

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in GH Research PLC are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating basic indicators, GH Research may actually be approaching a critical reversion point that can send shares even higher in January 2025.

PsyBio Therapeutics Corp

Risk-Adjusted Performance

8 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in PsyBio Therapeutics Corp are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak fundamental drivers, PsyBio Therapeutics reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with GH Research and PsyBio Therapeutics

The main advantage of trading using opposite GH Research and PsyBio Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GH Research position performs unexpectedly, PsyBio Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PsyBio Therapeutics will offset losses from the drop in PsyBio Therapeutics' long position.

The idea behind GH Research PLC and PsyBio Therapeutics Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.